Loading
A phase 2 trial of FLASH radiotherapy in Cutaneous squamous cell carcinoma and Basal cell carcinoma, run by Jules Bordet Institute, not yet recruiting.
Flash Radiotherapy for Skin Cancer is a phase 2 interventional study registered as NCT07455331 by Jules Bordet Institute, with 60 participants planned, started 2026-06-23 and due to reach its primary completion in 2029-12-23. Interventions recorded: FLASH radiotherapy, Conventional radiotherapy. Conditions recorded: Cutaneous Squamous Cell Carcinoma (CSCC), Basal Cell Carcinoma (BCC).
Linked to the technology FLASH radiotherapy because the registry names it ("flash radiotherapy") among its interventions and Cutaneous squamous cell carcinoma and Basal cell carcinoma among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Cutaneous squamous cell carcinoma, Basal cell carcinoma and the tag pipeline.
Shares Basal cell carcinoma and the tag pipeline.
Shares Basal cell carcinoma and the tag pipeline.
Shares Cutaneous squamous cell carcinoma and the tag pipeline.
Shares Basal cell carcinoma and the tag pipeline.
Shares Basal cell carcinoma and the tag pipeline.
Shares Cutaneous squamous cell carcinoma and the tag pipeline.
Shares Basal cell carcinoma and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/